ID30039A - Manik-manik baru farmasi pelepasan terkontrol metode pembuatannya dan formulasi berbagai unit yang mengandungnya - Google Patents

Manik-manik baru farmasi pelepasan terkontrol metode pembuatannya dan formulasi berbagai unit yang mengandungnya

Info

Publication number
ID30039A
ID30039A IDW00200101038A ID20011038A ID30039A ID 30039 A ID30039 A ID 30039A ID W00200101038 A IDW00200101038 A ID W00200101038A ID 20011038 A ID20011038 A ID 20011038A ID 30039 A ID30039 A ID 30039A
Authority
ID
Indonesia
Prior art keywords
control pharmaceutical
formulation
various units
units containing
control
Prior art date
Application number
IDW00200101038A
Other languages
English (en)
Indonesian (id)
Inventor
Torkel Gren
Anders Ringberg
Martin Wikberg
Randy J Wald
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20413266&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ID30039(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Publication of ID30039A publication Critical patent/ID30039A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
IDW00200101038A 1998-11-11 1999-11-11 Manik-manik baru farmasi pelepasan terkontrol metode pembuatannya dan formulasi berbagai unit yang mengandungnya ID30039A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9803871A SE9803871D0 (sv) 1998-11-11 1998-11-11 Therapeutic method and formulation

Publications (1)

Publication Number Publication Date
ID30039A true ID30039A (id) 2001-11-01

Family

ID=20413266

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW00200101038A ID30039A (id) 1998-11-11 1999-11-11 Manik-manik baru farmasi pelepasan terkontrol metode pembuatannya dan formulasi berbagai unit yang mengandungnya

Country Status (40)

Country Link
US (1) US6911217B1 (cs)
EP (1) EP1128819B1 (cs)
JP (1) JP3616011B2 (cs)
KR (1) KR100467384B1 (cs)
CN (1) CN1169522C (cs)
AP (1) AP1323A (cs)
AR (1) AR027815A1 (cs)
AT (1) ATE247458T1 (cs)
AU (1) AU762410B2 (cs)
BG (1) BG65149B1 (cs)
BR (1) BRPI9915142B8 (cs)
CA (1) CA2350061C (cs)
CZ (1) CZ299582B6 (cs)
DE (1) DE69910604T2 (cs)
DK (1) DK1128819T3 (cs)
EA (1) EA005074B1 (cs)
EE (1) EE05232B1 (cs)
ES (1) ES2204193T3 (cs)
GE (1) GEP20022833B (cs)
HK (1) HK1040917B (cs)
HR (1) HRP20010333B1 (cs)
HU (1) HU226582B1 (cs)
ID (1) ID30039A (cs)
IL (1) IL142809A0 (cs)
IS (1) IS2370B (cs)
MA (1) MA25325A1 (cs)
MY (1) MY122195A (cs)
NO (1) NO331399B1 (cs)
NZ (1) NZ511430A (cs)
OA (1) OA11673A (cs)
PL (1) PL195780B1 (cs)
PT (1) PT1128819E (cs)
RS (1) RS49891B (cs)
SE (1) SE9803871D0 (cs)
SI (1) SI1128819T1 (cs)
SK (1) SK284758B6 (cs)
TW (2) TWI267385B (cs)
UA (1) UA57165C2 (cs)
WO (1) WO2000027364A1 (cs)
ZA (1) ZA200103575B (cs)

Families Citing this family (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000515525A (ja) * 1996-07-19 2000-11-21 アベーグ，グンナー 尿と胃腸の疾患の治療におけるｓ（―）―トルテロジン
US8563522B2 (en) 1997-07-08 2013-10-22 The Iams Company Method of maintaining and/or attenuating a decline in quality of life
EP0957073A1 (en) * 1998-05-12 1999-11-17 Schwarz Pharma Ag Novel derivatives of 3,3-diphenylpropylamines
DE60021749T2 (de) * 1999-11-11 2006-04-20 Pfizer Health Ab Pharmazeutische formulierung enthaltend tolterodin sowie ihre verwendung
EP1536780A1 (en) * 2002-08-28 2005-06-08 Pharmacia Corporation Oral liquid tolterodine composition
US8168170B2 (en) 2002-10-03 2012-05-01 The Procter And Gamble Company Compositions having an inner core and at least three surrounding layers
WO2004064821A1 (en) * 2003-01-22 2004-08-05 Pfizer Health Ab Reduced dose of tolterodine and other antimuscarinic agents for treating urinary disorders
DE10315917A1 (de) * 2003-04-08 2004-11-18 Schwarz Pharma Ag Hochreine Basen von 3,3-Diphenylpropylaminmonoestern
EP2112920B1 (en) 2003-06-26 2018-07-25 Intellipharmaceutics Corp. Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
US8709476B2 (en) 2003-11-04 2014-04-29 Supernus Pharmaceuticals, Inc. Compositions of quaternary ammonium compounds containing bioavailability enhancers
PT2210605T (pt) 2003-11-04 2017-04-24 Tcd Royalty Sub Llc Formas de dosagem única diária de tróspio
US8894991B2 (en) 2003-12-19 2014-11-25 The Iams Company Canine probiotic Lactobacilli
US7785635B1 (en) 2003-12-19 2010-08-31 The Procter & Gamble Company Methods of use of probiotic lactobacilli for companion animals
US20050152884A1 (en) 2003-12-19 2005-07-14 The Procter & Gamble Company Canine probiotic Bifidobacteria globosum
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US8394409B2 (en) * 2004-07-01 2013-03-12 Intellipharmaceutics Corp. Controlled extended drug release technology
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
EP1629834A1 (en) 2004-08-27 2006-03-01 KRKA, D.D., Novo Mesto Sustained release pharmaceutical composition of tolterodine
CA2590556A1 (en) * 2005-01-10 2006-07-13 Teva Pharmaceutical Industries Ltd. Process for preparing tolterodine tartrate
AU2006253006B8 (en) 2005-05-31 2011-09-15 Alimentary Health Ltd Feline probiotic Lactobacilli
JP4938006B2 (ja) 2005-05-31 2012-05-23 ザ・アイムス・カンパニー ネコ科動物プロバイオティク・ビフィドバクテリア
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
ES2559678T3 (es) 2006-01-18 2016-02-15 Intec Pharma Ltd. Método para formar dispositivos de suministro para la vía oral de un agente
ES2904546T3 (es) 2006-02-03 2022-04-05 Opko Renal Llc Tratamiento de la insuficiencia y deficiencia de vitamina D con 25-hidroxivitamina D2 y 25-hidroxivitamina D3
KR100714058B1 (ko) * 2006-02-06 2007-05-02 한국유나이티드제약 주식회사 톨테로딘 엘-주석산염의 서방형 경구투여 조성물 및 이의 제조 방법
CN101516356A (zh) * 2006-02-24 2009-08-26 特瓦制药工业有限公司 琥珀酸美托洛尔缓释片及其制备方法
KR20080106358A (ko) * 2006-03-21 2008-12-04 테바 파마슈티컬 인더스트리즈 리미티드 톨터로딘의 제어 방출 제형
EP1839649A1 (en) * 2006-03-31 2007-10-03 LEK Pharmaceuticals D.D. Coated formulations for tolterodine
CA2648280C (en) * 2006-04-03 2014-03-11 Isa Odidi Controlled release delivery device comprising an organosol coat
WO2007122015A1 (en) * 2006-04-21 2007-11-01 Synthon B.V. Tolterodine beads
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
EP2026766A1 (en) 2006-05-17 2009-02-25 Synthon B.V. Tablet composition with a prolonged release of tamsulosin
WO2008008608A2 (en) 2006-06-21 2008-01-17 Proventiv Therapeutics, Llc Method of treating and preventing secondary hyperparathyroidism
JP2008007458A (ja) * 2006-06-29 2008-01-17 Freunt Ind Co Ltd レイヤリング用核粒子とその製造方法
WO2008066789A2 (en) 2006-11-27 2008-06-05 H. Lundbeck A/S Heteroaryl amide derivatives
PL2124966T3 (pl) 2007-02-01 2016-01-29 Iams Europe B V Sposób zmniejszania reakcji zapalnej i stresu u ssaków za pomocą antymetabolitów glukozy, awokado lub ekstraktów awokado
PL2148661T3 (pl) 2007-04-25 2013-07-31 Cytochroma Inc Doustne kompozycje o kontrolowanym uwalnianiu zawierające związek będący witaminą D i woskowy nośnik
US20100144684A1 (en) 2007-04-25 2010-06-10 Proventiv Therapeutics, Inc. Method of Safely and Effectively Treating and Preventing Secondary Hyperparathyroidism in Chronic Kidney Disease
JP5444212B2 (ja) 2007-04-25 2014-03-19 シトクロマ インコーポレイテッド ビタミンｄ不足および欠乏症の治療方法
WO2009003724A1 (en) * 2007-07-03 2009-01-08 Synthon B.V. Tolterodine bead
US8110226B2 (en) * 2007-07-20 2012-02-07 Mylan Pharmaceuticals Inc. Drug formulations having inert sealed cores
US8486452B2 (en) * 2007-07-20 2013-07-16 Mylan Pharmaceuticals Inc. Stabilized tolterodine tartrate formulations
EP2175843B1 (en) * 2007-08-08 2014-10-08 Inventia Healthcare Private Limited Extended release compositions comprising tolterodine
PL2187873T3 (pl) 2007-08-13 2019-01-31 Abuse Deterrent Pharmaceutical Llc Leki odporne na nadużywanie, metoda stosowania i metoda wytwarzania
US20090192228A1 (en) * 2008-01-28 2009-07-30 Actavis Group Ptc Ehf Controlled-Release Tolterodine Compositions and Methods
US20090214665A1 (en) * 2008-02-26 2009-08-27 Lai Felix S Controlled Release Muscarinic Receptor Antagonist Formulation
CA2629099A1 (en) * 2008-04-01 2009-10-01 Pharmascience Inc. Novel oral controlled release pharmaceutical formulations
KR101852042B1 (ko) 2008-04-02 2018-04-25 사이토크로마 인코포레이티드 비타민 ｄ 결핍 및 관련 장애에 유용한 방법, 조성물, 용도 및 키트
US20090311317A1 (en) * 2008-05-14 2009-12-17 Capricorn Pharma Inc. Modified release tolterodine formulations
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US8465770B2 (en) 2008-12-24 2013-06-18 Synthon Bv Low dose controlled release tablet
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
EP2459180A1 (en) * 2009-07-31 2012-06-06 Ranbaxy Laboratories Limited Multi-layered, multiple unit pharmaceutical compositions
WO2011061616A2 (en) 2009-11-23 2011-05-26 Micro Labs Limited Extended release compositions containing tolterodine and process for preparing the same
WO2011095388A1 (en) 2010-02-04 2011-08-11 Synthon Bv Tolterodine bead
ES2783980T3 (es) 2010-03-29 2020-09-21 Opko Ireland Global Holdings Ltd Métodos y composiciones para la reducción de niveles de paratiroides
CN102834091B (zh) 2010-03-29 2015-04-22 辉凌公司 一种快速溶解药物组合物
JO3112B1 (ar) 2010-03-29 2017-09-20 Ferring Bv تركيبة دوائية سريعة التحلل
AU2011245499B2 (en) 2010-04-30 2014-09-25 Merck Sharp & Dohme Corp. Novel beta 3 adrenergic receptor agonists
US20120040008A1 (en) * 2010-08-11 2012-02-16 Ashish Chatterji Pharmaceutical compositions of metabotropic glutamate 5 receptor (mglu5) antagonists
WO2012154770A1 (en) 2011-05-10 2012-11-15 Theravida, Inc. Combinations of tolterodine and salivary stimulants for the treatment of overactive bladder
GR1007628B (el) 2011-07-27 2012-06-29 Φαρματεν Αβεε, Φαρμακευτικο σκευασμα περιεχον εναν αντιμουσκαρινικο παραγοντα και μεθοδος για την παρασκευη αυτου
NZ620897A (en) 2011-09-16 2016-07-29 Ferring Bv A fast dissolving pharmaceutical composition
US20140242158A1 (en) * 2011-09-30 2014-08-28 Astellas Pharma, Inc. Granular Pharmaceutical Composition
NZ702967A (en) 2012-07-12 2017-07-28 Ferring Bv Diclofenac formulations
JP2015529255A (ja) * 2012-09-20 2015-10-05 オーエイチアール ファーマ， エルエルシーＯｈｒ Ｐｈａｒｍａ， Ｌｌｃ 治療薬の持続放出のための多層の生体分解可能なマイクロ粒子
US20150306170A1 (en) * 2012-11-21 2015-10-29 Ferring B.V. Composition for immediate and extended release
TW201422254A (zh) 2012-11-21 2014-06-16 Ferring Bv 用於速釋及延釋的組成物
HUE050303T2 (hu) * 2013-03-13 2020-11-30 Intervet Int Bv Stabil bioaktív szubsztanciák és eljárások elõállítására
US20140275038A1 (en) 2013-03-15 2014-09-18 Inspirion Delivery Technologies, Llc Abuse deterrent compositions and methods of use
KR101847947B1 (ko) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 안정화되고 변형된 비타민 ｄ 방출 제형
AU2014246617A1 (en) 2013-12-23 2015-07-09 Sun Pharmaceutical Industries Limited Multi-layered, multiple unit pharmaceutical compositions
SG11201700858RA (en) 2014-08-07 2017-03-30 Opko Ireland Global Holdings Ltd Adjunctive therapy with 25-hydroxyvitamin d
US10729685B2 (en) 2014-09-15 2020-08-04 Ohemo Life Sciences Inc. Orally administrable compositions and methods of deterring abuse by intranasal administration
CA2902911C (en) * 2014-10-31 2017-06-27 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
EP3431107A4 (en) * 2016-02-23 2019-11-13 Nipro Corporation PARTICULARS OF A PHARMACEUTICAL COMPOSITION AND MOUTH-DISTURBING PREPARATION THEREOF
TWI747893B (zh) 2016-03-28 2021-12-01 愛爾蘭商歐科愛爾蘭全球控股股份有限公司 維生素ｄ治療之方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1144911B (it) * 1981-03-19 1986-10-29 Pharmatec Spa Composizione farmaceutica a rilascio controllato contenente ibuprofen
JPH07107450A (ja) 1993-10-08 1995-04-21 Hitachi Ltd 情報通信装置
JP3453186B2 (ja) 1994-04-14 2003-10-06 共和薬品工業株式会社 徐放性マイクロカプセルおよびその製造方法
SE9402422D0 (sv) * 1994-07-08 1994-07-08 Astra Ab New beads for controlled release and a pharmaceutical preparation containing the same
US5645858A (en) * 1994-10-06 1997-07-08 Ortho Pharmaceutical Corporation Multilayered controlled release pharmaceutical dosage form
US5567441A (en) * 1995-03-24 1996-10-22 Andrx Pharmaceuticals Inc. Diltiazem controlled release formulation
JP2000515525A (ja) 1996-07-19 2000-11-21 アベーグ，グンナー 尿と胃腸の疾患の治療におけるｓ（―）―トルテロジン
US6312728B1 (en) * 1998-07-07 2001-11-06 Cascade Development, Inc. Sustained release pharmaceutical preparation

Also Published As

Publication number Publication date
SI1128819T1 (en) 2003-12-31
IS5936A (is) 2001-05-09
US6911217B1 (en) 2005-06-28
DE69910604D1 (de) 2003-09-25
IL142809A0 (en) 2002-03-10
EP1128819A1 (en) 2001-09-05
CA2350061A1 (en) 2000-05-18
HRP20010333A2 (en) 2003-04-30
HUP0105038A3 (en) 2006-07-28
CN1326339A (zh) 2001-12-12
BR9915142A (pt) 2001-08-07
BRPI9915142B1 (pt) 2015-08-25
EE200100254A (et) 2002-12-16
SK6252001A3 (en) 2002-01-07
MA25325A1 (fr) 2001-12-31
PL195780B1 (pl) 2007-10-31
ATE247458T1 (de) 2003-09-15
HK1040917A1 (en) 2002-06-28
GEP20022833B (en) 2002-11-25
PT1128819E (pt) 2003-12-31
NO331399B1 (no) 2011-12-19
JP3616011B2 (ja) 2005-02-02
HK1040917B (zh) 2005-05-27
KR20010075695A (ko) 2001-08-09
DE69910604T2 (de) 2004-06-24
SK284758B6 (sk) 2005-11-03
AR027815A1 (es) 2003-04-16
UA57165C2 (uk) 2003-06-16
YU33101A (sh) 2003-10-31
KR100467384B1 (ko) 2005-01-24
HUP0105038A2 (en) 2002-06-29
ES2204193T3 (es) 2004-04-16
EA005074B1 (ru) 2004-10-28
CN1169522C (zh) 2004-10-06
AU762410B2 (en) 2003-06-26
HRP20010333B1 (en) 2004-10-31
AU1436600A (en) 2000-05-29
NZ511430A (en) 2003-05-30
BG105582A (en) 2001-12-29
AP1323A (en) 2004-11-05
RS49891B (sr) 2008-08-07
ZA200103575B (en) 2002-05-03
EA200100538A1 (ru) 2001-10-22
EE05232B1 (et) 2009-12-15
TWI267385B (en) 2006-12-01
WO2000027364A1 (en) 2000-05-18
CZ20011627A3 (cs) 2001-10-17
BRPI9915142B8 (pt) 2021-05-25
CA2350061C (en) 2005-05-17
NO20012314L (no) 2001-07-09
PL348612A1 (en) 2002-06-03
HU226582B1 (en) 2009-04-28
OA11673A (en) 2005-01-12
IS2370B (is) 2008-06-15
SE9803871D0 (sv) 1998-11-11
DK1128819T3 (da) 2003-12-01
JP2003517446A (ja) 2003-05-27
NO20012314D0 (no) 2001-05-10
MY122195A (en) 2006-03-31
CZ299582B6 (cs) 2008-09-10
AP2001002166A0 (en) 2001-06-30
TWI222879B (en) 2004-11-01
EP1128819B1 (en) 2003-08-20
BG65149B1 (bg) 2007-04-30

Similar Documents

Publication Publication Date Title
ID30039A (id) Manik-manik baru farmasi pelepasan terkontrol metode pembuatannya dan formulasi berbagai unit yang mengandungnya
ID18320A (id) Produk obat baru dan penggunaan daripadanya
ID22426A (id) Ketobenzamida yang baru dan penggunaannya
ID25543A (id) Alpha-aril-n-alkinitron dan komposisi farmasi yang mengandungnya
ID21806A (id) Bentuk penakaran farmasi yang secara cepat dilepaskan dan yang menutup rasa
ID28653A (id) Kolom gelembung udara dan penggunannya
ID18925A (id) Penggunaan benzazol-benzazol yang disubstitusi sebagai absorben-absorben uv, benzazol-benzazol baru dan proses-proses untuk pembuatannya
ID22490A (id) Benzamida-benzamida yang disubstitusi secara heterosiklik yang baru dan penggunaannya
ID26248A (id) Turunan asiguanidina baru sebagai inhibitor penyerapan tulang dan sebagai antagonis reseptor vitronektin
ID19479A (id) Turunan-turunan amidino baru dan pemakaian sebagai penghambat-penghambat trombin
ID25469A (id) Komposisi sefalosporin amorf yang stabil secara kristalografi dan proses pembuatannya
ID17128A (id) Granulat untuk pembuatan komposisi-komposisi cepat mengurai dan cepat larut yang mengandung jumlah obat yang tinggi
NO984094D0 (no) Utladningsreaktor og anvendelse av samme
ID27558A (id) Amida-amida aromatik baru, metode pembuatannya dan penggunaannya sebagai obat
NO971811D0 (no) Bicykliske tetrahydropyrazolopyridiner og deres anvendelse som legemidler
ID24714A (id) Turunan tiazolidindion tersubstitusi, proses pembuatannya dan penggunaan bahan farmasinya
HUP0000189A3 (en) Bicyclic aryl carboxamides pharmaceutical compositions containing them and their therapeutic use
ID20604A (id) Polisakarida sintetis proses untuk pembuatan dan komposisi farmasi yang dikandungnya
ID22283A (id) Kombinasi terapi baru dari zat-zat mirtazapin dan antipsikotik untuk perawatan atau propilaksis gangguan psikotik
ID24259A (id) Formulasi obat yang memiliki pelepasan senyawa aktif terkontrol
ID18682A (id) Asiltransferase dan plasma yang mengkodekan asiltransferase
ID22911A (id) Turunan-turunan triazol baru, proses pembuatan dan komposisi-komposisi farmasi yang mengandungnya
ID24716A (id) Formulasi baru
ID17199A (id) Mikro-organisme pengurai hidrokarbon yang mengandung halogen dan pemakaiannya
DE69420178D1 (de) Flüssigkeitsauftragegerät und Herstellung desselben